Glucocorticoid-Mediated Modulation of Eosinopoiesis in Asthma: A Paradoxical Duality
Allergies · 06.10.2025 · 5 (4) · 35
DOI: 10.3390/allergies5040035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergies, online erschienen am 06.10.2025. Verfasst von Bruno Marques Vieira. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FAPERJ—Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, CNPq—Conselho Nacional de Desenvolvimento Científico e Tecnológico, IDEAS—Instituto de Desenvolvimento, Ensino e Assistência à Saúde.
Abstract (Originalsprache)
Glucocorticoids (GCs) remain the cornerstone of asthma treatment due to their potent anti-inflammatory and eosinophil-suppressive effects in the airways, including the induction of peripheral eosinophil apoptosis and downregulation of type 2 cytokine signaling. However, emerging evidence reveals a paradoxical role for GCs in the bone marrow, where they enhance eosinophil production (eosinopoiesis), especially under allergic, infectious, or surgical stress conditions. This duality reflects a complex immunoendocrine interplay involving GC-induced modulation of eosinophil progenitor survival, proliferation, and responsiveness to eosinopoietic cytokines such as interleukin-5 and granulocyte-macrophage colony-stimulating factor. Furthermore, GCs synergize with lipid mediators like cysteinyl-leukotrienes and prostaglandins, modulating both transcriptional and adhesion molecule profiles that prime eosinophil precursors for migration and differentiation. This review examines the molecular and cellular mechanisms underlying GC-induced eosinopoiesis, its functional link to airway inflammation, and its clinical implications for asthma management. We also explore potential therapeutic strategies aimed at selectively modulating bone marrow eosinophil output without compromising the peripheral anti-inflammatory benefits of GCs. Understanding this paradoxical duality holds significant translational potential for improving disease control and preventing asthma exacerbations.
Förderung
- FAPERJ—Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- CNPq—Conselho Nacional de Desenvolvimento Científico e Tecnológico
- IDEAS—Instituto de Desenvolvimento, Ensino e Assistência à Saúde
Zitieren
APA
Vieira, B. M. (2025). Glucocorticoid-Mediated Modulation of Eosinopoiesis in Asthma: A Paradoxical Duality. Allergies, 5(4), 35. https://doi.org/10.3390/allergies5040035
Vancouver
Vieira BM. Glucocorticoid-Mediated Modulation of Eosinopoiesis in Asthma: A Paradoxical Duality. Allergies. 2025;5(4):35. doi:10.3390/allergies5040035
BibTeX
@article{Vieira2025,
author = {Vieira, Bruno Marques},
title = {Glucocorticoid-Mediated Modulation of Eosinopoiesis in Asthma: A Paradoxical Duality},
journal = {Allergies},
year = {2025},
volume = {5},
number = {4},
pages = {35},
doi = {10.3390/allergies5040035}
}
EUVIMED